Overview
Fumihito Ono practices practicing medicine in Osaka, Japan.
Ono is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Retinopathy Pigmentary Mental Retardation, Bladder Cancer, and Urothelial Cancer.
They are actively involved in clinical research, co-authoring 40 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Fumihito Ono
Is Fumihito Ono a top-rated expert for Retinopathy Pigmentary Mental Retardation?
MediFind is an objective health platform that identifies experts based on real-world data. Fumihito Ono is classified as an Advanced expert for Retinopathy Pigmentary Mental Retardation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fumihito Ono participate in research or clinical trials?
Yes. Fumihito Ono has published 40 articles and abstracts on conditions like Retinopathy Pigmentary Mental Retardation. You can view a list of Fumihito Ono's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Retinopathy Pigmentary Mental Retardation
- Experienced
- Bladder CancerOno isExperienced. Learn about Bladder Cancer.
- Urothelial CancerOno isExperienced. Learn about Urothelial Cancer.